Title:
PROPHYLACTIC OR THERAPEUTIC AGENT FOR CHRONIC KIDNEY DISEASE
Document Type and Number:
WIPO Patent Application WO/2019/082912
Kind Code:
A1
Abstract:
A prophylactic or therapeutic agent for chronic kidney disease which comprises, as an active ingredient, a substance capable of increasing the expression amount of ganglioside GM3.
Inventors:
KAWASHIMA NAGAKO (JP)
NAITO SHOKICHI (JP)
NAITO SHOKICHI (JP)
Application Number:
PCT/JP2018/039434
Publication Date:
May 02, 2019
Filing Date:
October 24, 2018
Export Citation:
Assignee:
SCHOOL JURIDICAL PERSON THE KITASATO INST (JP)
International Classes:
A61K45/00; A61K31/19; A61P13/12; A61P43/00; C12Q1/02; C12Q1/68; G01N33/15; G01N33/50; G01N33/68
Foreign References:
| JP2011502174A | 2011-01-20 | |||
| US20160311812A1 | 2016-10-27 |
Other References:
KAWAOKA, KOICHIRO ET AL.: "Valproic acid attenuates renal fibrosis through the induction of autophagy", CLINICAL AND EXPERIMENTAL NEPHROLOGY, vol. 21, 7 December 2016 (2016-12-07), pages 771 - 780, XP036342401, ISSN: 1342-1751, DOI: doi:10.1007/s10157-016-1365-6
Attorney, Agent or Firm:
TANAI Sumio et al. (JP)
Download PDF: